2H
2HE.F Healthequity Inc
- Market cap
- EUR 7.65B
- P/E
- 39.5x
- P/B
- 4.20x
- ROE
- 13.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.
Is 2HE.F undervalued?
Graham number2HE.F trades 171.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Healthequity Inc fundamental analysis
No fundamental analysis for Healthequity Inc yet.
Healthequity Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Healthequity Inc
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as admini…
Full company profileHealthequity Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Healthequity Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 178M | 230M | 287M | 532M | 734M | 757M | 862M | 1,000M | 1.20B | 1.31B | 1.41B |
| Gross Profit | 106M | 135M | 181M | 326M | 415M | 424M | 490M | 623M | 777M | 913M | 1.03B |
| Operating Income | 41.2M | 54.4M | 77.7M | 109M | 80.0M | 40.6M | 37.7M | 128M | 203M | 327M | 407M |
| EBITDA | - | 70.4M | 95.9M | 123M | 155M | 107M | 172M | 284M | 339M | 489M | 571M |
| Net Income | 26.4M | 47.4M | 73.9M | 39.7M | 8.83M | -44.3M | -26.1M | 55.7M | 96.7M | 215M | 270M |
| EPS | - | 0.78 | 1.18 | 0.56 | 0.11 | -0.53 | -0.31 | 0.65 | 1.12 | 2.53 | 3.26 |
| Balance Sheet | |||||||||||
| Total Assets | 279M | 369M | 510M | 2.56B | 2.71B | 3.11B | 3.09B | 3.16B | 3.45B | 3.38B | 3.27B |
| Total Liabilities | 17.2M | 22.9M | 32.9M | 1.53B | 1.33B | 1.25B | 1.19B | 1.13B | 1.33B | 1.27B | 1.28B |
| Shareholders' Equity | 262M | 346M | 477M | 1.03B | 1.38B | 1.85B | 1.90B | 2.04B | 2.11B | 2.11B | 1.99B |
| Cash & Short-term Investments | 140M | 199M | 361M | 192M | 329M | 225M | 254M | 404M | 296M | 319M | 256M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 45.6M | 81.7M | 113M | 105M | 182M | 141M | 151M | 243M | 340M | 457M | 467M |
| Capital Expenditure | 12.7M | 5.46M | 3.87M | 7.29M | 13.1M | 8.91M | 3.37M | 46.1M | 505M | 48.8M | 64.1M |
| Free Cash Flow | - | 48.3M | 98.4M | 62.9M | 84.7M | 3.91M | 31.5M | 197M | -166M | 408M | 403M |
| Ratios | |||||||||||
| ROE | 10.1% | 13.7% | 15.5% | 3.8% | 0.6% | -2.4% | -1.4% | 2.7% | 4.6% | 10.2% | 13.6% |
| ROA | 9.4% | 12.8% | 14.5% | 1.5% | 0.3% | -1.4% | -0.8% | 1.8% | 2.8% | 6.4% | 8.3% |
| Net Profit Margin | 14.8% | 20.6% | 25.7% | 7.5% | 1.2% | -5.9% | -3.0% | 5.6% | 8.1% | 16.4% | 19.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Healthequity Inc dividends
Healthequity Inc has not paid dividends in the last 9 fiscal years.
Who owns Healthequity Inc
- Insiders 2.17%
- Institutions 97.83%
- Public & others 0.00%
- Shares outstanding 82.7M
- Free float 81.0M
Healthequity Inc company profile
- Company name
- Healthequity Inc
- Ticker
- 2HE.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 2,814
- Fiscal year end
- January
- Address
- 15 West Scenic Pointe Drive, Draper, UT, United States, 84020
- Phone
- 801 727 1000
- Website
- healthequity.com
About Healthequity Inc
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Healthequity Inc management
10- Mr. Scott R. Cutler J.D.CEO, President & Director · born 1970
- Dr. Stephen D. Neeleman M.D.Founder & Vice Chairman · born 1968
- Mr. James M. LucaniaCFO & Executive VP · born 1979
- Mr. Delano Ladd J.D.Executive VP, General Counsel & Secretary · born 1981
- Mr. Richard PutnamVice President of Investor Relations
- Ms. Stacey UllrichSenior Vice President of Corporate Communications
- Mr. Steve LindsayExecutive Vice President of Sales & Relationship Management
- Mr. Brad BennionExecutive Vice President of Corporate Development & Strategy
- Mr. Mukund RamachandranChief Marketing Officer
- Ms. Cheryl KingExecutive VP & Chief People Officer